{"id":"https://openalex.org/W2052483630","doi":"https://doi.org/10.1002/art.21540","title":"More pronounced inhibition of cyclooxygenase 2, increase in blood pressure, and reduction of heart rate by treatment with diclofenac compared with celecoxib and rofecoxib","display_name":"More pronounced inhibition of cyclooxygenase 2, increase in blood pressure, and reduction of heart rate by treatment with diclofenac compared with celecoxib and rofecoxib","alternate_titles":[],"publication_year":2005,"publication_date":"2005-12-29","ids":{"openalex":"https://openalex.org/W2052483630","doi":"https://doi.org/10.1002/art.21540","mag":"2052483630","pmid":"https://pubmed.ncbi.nlm.nih.gov/16385545"},"language":"en","primary_location":{"id":"doi:10.1002/art.21540","doi":"https://doi.org/10.1002/art.21540","is_oa":false,"landing_page_url":"https://doi.org/10.1002/art.21540","pdf_url":null,"source":{"id":"https://openalex.org/S132787887","display_name":"Arthritis & Rheumatism","issn_l":"0004-3591","issn":["0004-3591","1529-0131"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Arthritis &amp; Rheumatism","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2052483630"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5088386473","display_name":"Burkhard Hinz","orcid":"https://orcid.org/0000-0002-2529-0732","observed_orcids":["https://orcid.org/0000-0002-2529-0732"]},"institutions":[{"id":"https://openalex.org/I181369854","display_name":"Friedrich-Alexander-Universit\u00e4t Erlangen-N\u00fcrnberg","ror":"https://ror.org/00f7hpc57","country_code":"DE","type":"education","lineage":["https://openalex.org/I181369854"]}],"countries":["DE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Burkhard Hinz","raw_affiliation_strings":["Dept. of Experimental and Clinical Pharmacology and Toxicology, Friedrich Alexander University Erlangen-N\u00fcrnberg, Fahrstrasse 17, D-91054 Erlangen, Germany. hinz@pharmaklologie.uni-erlangen.de","Friedrich-Alexander Univ. Erlangen-Nurnberg, Erlangen, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dept. of Experimental and Clinical Pharmacology and Toxicology, Friedrich Alexander University Erlangen-N\u00fcrnberg, Fahrstrasse 17, D-91054 Erlangen, Germany. hinz@pharmaklologie.uni-erlangen.de","institution_ids":["https://openalex.org/I181369854"]},{"raw_affiliation_string":"Friedrich-Alexander Univ. Erlangen-Nurnberg, Erlangen, Germany","institution_ids":["https://openalex.org/I181369854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086975354","display_name":"Harald Dormann","orcid":"https://orcid.org/0000-0002-6993-8836","observed_orcids":["https://orcid.org/0000-0002-6993-8836"]},"institutions":[{"id":"https://openalex.org/I181369854","display_name":"Friedrich-Alexander-Universit\u00e4t Erlangen-N\u00fcrnberg","ror":"https://ror.org/00f7hpc57","country_code":"DE","type":"education","lineage":["https://openalex.org/I181369854"]}],"countries":["DE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Harald Dormann","raw_affiliation_strings":["Friedrich-Alexander Univ. Erlangen-Nurnberg, Erlangen, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Friedrich-Alexander Univ. Erlangen-Nurnberg, Erlangen, Germany","institution_ids":["https://openalex.org/I181369854"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5027292872","display_name":"Kay Brune","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I181369854","display_name":"Friedrich-Alexander-Universit\u00e4t Erlangen-N\u00fcrnberg","ror":"https://ror.org/00f7hpc57","country_code":"DE","type":"education","lineage":["https://openalex.org/I181369854"]}],"countries":["DE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Kay Brune","raw_affiliation_strings":["Friedrich-Alexander Univ. Erlangen-Nurnberg, Erlangen, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Friedrich-Alexander Univ. Erlangen-Nurnberg, Erlangen, Germany","institution_ids":["https://openalex.org/I181369854"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I181369854"],"apc_list":null,"apc_paid":null,"fwci":4.2921,"has_fulltext":false,"cited_by_count":64,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.94592751,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":86,"max":96},"biblio":{"volume":"54","issue":"1","first_page":"282","last_page":"291"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10678","display_name":"Inflammatory mediators and NSAID effects","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10678","display_name":"Inflammatory mediators and NSAID effects","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12910","display_name":"Eicosanoids and Hypertension Pharmacology","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1303","display_name":"Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.0,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cox-2-inhibition","display_name":"COX-2 inhibition","score":0.890999972820282},{"id":"https://openalex.org/keywords/diclofenac","display_name":"diclofenac","score":0.9929999709129333},{"id":"https://openalex.org/keywords/celecoxib","display_name":"celecoxib","score":1.0},{"id":"https://openalex.org/keywords/rofecoxib","display_name":"rofecoxib","score":1.0},{"id":"https://openalex.org/keywords/cox-2-inhibitors","display_name":"COX-2 inhibitors","score":0.765999972820282},{"id":"https://openalex.org/keywords/cardiovascular-side-effects","display_name":"cardiovascular side effects","score":0.6899999976158142},{"id":"https://openalex.org/keywords/blood-pressure","display_name":"blood pressure","score":0.8579999804496765},{"id":"https://openalex.org/keywords/heart-rate","display_name":"heart rate","score":0.9769999980926514},{"id":"https://openalex.org/keywords/prostaglandin-e2-synthesis","display_name":"prostaglandin E2 synthesis","score":0.9520000219345093},{"id":"https://openalex.org/keywords/lipopolysaccharide","display_name":"lipopolysaccharide","score":0.8619999885559082},{"id":"https://openalex.org/keywords/nonsteroidal-anti-inflammatory-drugs","display_name":"nonsteroidal anti-inflammatory drugs","score":0.8270000219345093},{"id":"https://openalex.org/keywords/older-volunteers","display_name":"elderly volunteers","score":0.5720000267028809}],"concepts":[{"id":"https://openalex.org/C2778582115","wikidata":"https://www.wikidata.org/wiki/Q411412","display_name":"Rofecoxib","level":4,"score":0.9915856122970581},{"id":"https://openalex.org/C2776467144","wikidata":"https://www.wikidata.org/wiki/Q408801","display_name":"Celecoxib","level":2,"score":0.9469140768051147},{"id":"https://openalex.org/C2779826273","wikidata":"https://www.wikidata.org/wiki/Q244408","display_name":"Diclofenac","level":2,"score":0.9415324330329895},{"id":"https://openalex.org/C2779689624","wikidata":"https://www.wikidata.org/wiki/Q410251","display_name":"Cyclooxygenase","level":3,"score":0.7746409773826599},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6604964137077332},{"id":"https://openalex.org/C84393581","wikidata":"https://www.wikidata.org/wiki/Q82642","display_name":"Blood pressure","level":2,"score":0.6587706804275513},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.584649384021759},{"id":"https://openalex.org/C2777953023","wikidata":"https://www.wikidata.org/wiki/Q1073121","display_name":"Heart rate","level":3,"score":0.4945332705974579},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.44372236728668213},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2991955876350403},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.18010523915290833},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.07080826163291931},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.07030895352363586}],"mesh":[{"descriptor_ui":"D000068579","descriptor_name":"Celecoxib","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001794","descriptor_name":"Blood Pressure","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D004008","descriptor_name":"Diclofenac","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006339","descriptor_name":"Heart Rate","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007783","descriptor_name":"Lactones","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011720","descriptor_name":"Pyrazoles","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D013449","descriptor_name":"Sulfonamides","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D013450","descriptor_name":"Sulfones","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D051546","descriptor_name":"Cyclooxygenase 2","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D052246","descriptor_name":"Cyclooxygenase 2 Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1002/art.21540","doi":"https://doi.org/10.1002/art.21540","is_oa":false,"landing_page_url":"https://doi.org/10.1002/art.21540","pdf_url":null,"source":{"id":"https://openalex.org/S132787887","display_name":"Arthritis & Rheumatism","issn_l":"0004-3591","issn":["0004-3591","1529-0131"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Arthritis &amp; Rheumatism","raw_type":"journal-article"},{"id":"pmid:16385545","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16385545","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Arthritis and rheumatism","raw_type":"Comparative Study"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Randomized Controlled Trial","id":"https://openalex.org/study-designs/randomized-controlled-trial"},{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":40,"referenced_works":["https://openalex.org/W6953988","https://openalex.org/W1859425235","https://openalex.org/W1922681024","https://openalex.org/W1971274379","https://openalex.org/W1986175380","https://openalex.org/W1998167638","https://openalex.org/W2001162433","https://openalex.org/W2008568394","https://openalex.org/W2009522154","https://openalex.org/W2011291552","https://openalex.org/W2012583441","https://openalex.org/W2018035901","https://openalex.org/W2018716226","https://openalex.org/W2020563114","https://openalex.org/W2022106950","https://openalex.org/W2038932922","https://openalex.org/W2044184763","https://openalex.org/W2057685090","https://openalex.org/W2063535984","https://openalex.org/W2065122851","https://openalex.org/W2074690324","https://openalex.org/W2077614134","https://openalex.org/W2084443721","https://openalex.org/W2089288753","https://openalex.org/W2096198355","https://openalex.org/W2106038135","https://openalex.org/W2107550347","https://openalex.org/W2127296471","https://openalex.org/W2137408480","https://openalex.org/W2138224872","https://openalex.org/W2139776244","https://openalex.org/W2158131645","https://openalex.org/W2158968701","https://openalex.org/W2162138099","https://openalex.org/W2162582390","https://openalex.org/W2163756514","https://openalex.org/W2240026871","https://openalex.org/W2267272397","https://openalex.org/W2330496155","https://openalex.org/W2398560052"],"related_works":["https://openalex.org/W2037622397","https://openalex.org/W7117465481","https://openalex.org/W7042525157","https://openalex.org/W2018035901","https://openalex.org/W1494199079","https://openalex.org/W3121626603","https://openalex.org/W2144398034","https://openalex.org/W2123175521","https://openalex.org/W2518339160"],"abstract_inverted_index":{"OBJECTIVE:":[0],"Recent":[1],"findings":[2],"suggest":[3],"that":[4,237],"permanent":[5],"blockade":[6],"of":[7,20,39,59,115,133,231,243,252],"cyclooxygenase":[8],"2":[9],"(COX-2)":[10],"is":[11,235],"one":[12],"factor":[13],"contributing":[14],"to":[15,204,264],"the":[16,34,43,197,205,221,238,249],"cardiovascular":[17,46,253],"side":[18,254],"effects":[19,44,255],"selective":[21],"COX-2":[22,40,120,134,141,194,224,245],"inhibitors":[23],"(coxibs)":[24],"and":[25,36,42,52,62,102,111,119,151,162,171,176,180,182,201,212,229,240,259],"nonsteroidal":[26],"antiinflammatory":[27],"drugs":[28],"(NSAIDs).":[29],"The":[30],"present":[31],"study":[32,72],"compared":[33],"extent":[35,239],"time":[37,105,241],"course":[38,242],"inhibition":[41,142,195,246],"on":[45,108],"parameters":[47],"(changes":[48],"in":[49,64,75,136,208,215,267],"blood":[50,210,226],"pressure":[51,211,227],"heart":[53,216,232],"rate)":[54],"between":[55],"various":[56],"antirheumatic":[57],"doses":[58],"diclofenac,":[60,174],"celecoxib,":[61,179],"rofecoxib":[63,91,152],"healthy":[65],"elderly":[66],"volunteers.":[67],"METHODS:":[68],"A":[69],"randomized,":[70],"parallel-group":[71],"was":[73,126,143],"conducted":[74],"volunteers":[76],"receiving":[77],"75":[78],"mg":[79,84,90],"diclofenac":[80,190],"twice":[81,86],"daily,":[82,87],"200":[83],"celecoxib":[85,150],"or":[88],"25":[89],"once":[92],"daily":[93],"for":[94,113],"8":[95],"days.":[96],"Blood":[97],"samples":[98],"were":[99,167],"obtained":[100],"predose":[101],"at":[103,163],"specified":[104],"points":[106],"postdose,":[107],"days":[109],"1":[110],"8,":[112],"assay":[114],"drug":[116],"plasma":[117],"concentrations":[118],"inhibition.":[121],"Lipopolysaccharide-induced":[122],"prostaglandin":[123],"E(2)":[124],"synthesis":[125],"measured":[127],"ex":[128],"vivo":[129],"as":[130,168],"an":[131],"index":[132],"activity":[135],"human":[137],"whole":[138,198],"blood.":[139],"RESULTS:":[140],"significantly":[144],"less":[145],"pronounced":[146,223],"after":[147,158],"treatment":[148],"with":[149,154,173,178,184,257],"than":[153],"diclofenac.":[155],"Maximal":[156],"inhibitions":[157],"a":[159],"single":[160],"dose":[161,199],"steady":[164,187],"state,":[165,188],"respectively,":[166],"follows:":[169],"99%":[170,172],"70%":[175],"81%":[177],"56%":[181],"72%":[183],"rofecoxib.":[185],"At":[186],"only":[189],"caused":[191],"virtually":[192],"complete":[193],"over":[196],"interval,":[200],"this":[202,262],"corresponded":[203],"highest":[206],"increase":[207],"systolic":[209],"greatest":[213],"reduction":[214],"rate.":[217,233],"CONCLUSION:":[218],"Diclofenac":[219],"elicited":[220],"most":[222],"inhibition,":[225],"elevation,":[228],"suppression":[230],"It":[234],"assumed":[236],"intravascular":[244],"may":[247],"determine":[248],"differential":[250],"profile":[251],"associated":[256],"NSAIDs":[258],"coxibs,":[260],"but":[261],"has":[263],"be":[265],"proven":[266],"future":[268],"studies.":[269]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2052483630","counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":2},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":3}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
